Receptos Inc

Most Recent

  • uploads///Part
    Company & Industry Overviews

    Anacor Pharmaceuticals Outperforms the Market

    Within IBB, stocks like Receptos and Celgene performed well. However, Anacor Pharmaceuticals outperformed everyone with an eye-catching 71.92% for the week ending July 17.

    By Peter Neil
  • uploads///Part
    Company & Industry Overviews

    Healthcare and Biotech Stocks Accelerate Their Longer-Term Trends

    As of July 17, 2015, 68.42% of the biotech sector within the iShares Nasdaq Biotechnology (IBB) stocks are trading above their 100-day moving average.

    By Peter Neil
  • uploads///Part
    Company & Industry Overviews

    Mergers and Acquisitions Drive the Biotech Sector

    Mergers and acquisitions continue to drive the biotech sector. In the week ending July 17, 2015, Celgene (CELG) acquired Receptos (RCPT) for ~$7.2 billion.

    By Peter Neil
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.